Skip to main content
. 2024 Aug 10;15:6845. doi: 10.1038/s41467-024-51352-3

Fig. 8. Proposed model.

Fig. 8

This study demonstrates that the ER-resident protein, Nogo-B, interacts with the MPGF of proGCG to retain proglucagon within the ER, thereby inhibiting the PCSK1-mediated cleavage of proGCG in the Golgi. The knockout of intestinal Nogo-B in mice with T2DM results in elevated levels of GLP1 and insulin, while reducing glucagon levels. Consequently, this alleviates pancreatic injury and improves insulin resistance.